Browse All

Current Filters

CLEAR FILTER x

TITLE

Tocilizumab and Satralizumab in MOGAD: Real-world Outcomes for Relapse Prevention

Author:Vilaseca-Jolonch, Andreu   Thakolwiboon, Smathorn   Syc-Mazurek, Stephanie   Cacciaguerra, Laura   Guo, Kai   Niederschweiberer, Moritz   Sagen, Jessica   Lopez-Chiriboga, Sebastian   Wingerchuk, Dean   Tillema, Jan-Mendelt   Pittock, Sean   Chen, John   Flanagan, Eoin   

Session Name:P3: Autoimmune Neurology: NMOSD/MOGAD 3  

Topic:Autoimmune Neurology  

Program Number:P3.002  

Author Institution:Mayo Clinic, Rochester, MN  Mayo Clinic Health System, La Crosse, WI  Mayo Clinic, Berlin, MN  Mayo Clinic, FL  Mayo Clinic, Scottsdale, AZ  Mayo Clinic Dept of Neurology, Rochester, MN  

A Genetic Triple Play: Adolescent-onset Hyperkinetic Syndrome with Multilocus KMT2B and FGF14 Variants and Familial Hunter Syndrome in One Pedigree

Author:Palakodeti, Sanjana   Khan, Hina Rmsha Alfia   Natteru, Prashant   

Session Name:P7: Movement Disorders: Hyperkinetic Movement Disorders 2  

Topic:Movement Disorders  

Program Number:P7.006  

Author Institution:Kamineni Institute of Medical Sciences, Hyderabad, India  Mayo Clinic Health System , la Crosse, WI  Mayo Clinic Health System, La Crosse, WI